EVOLUS

evolus-logo

Evolus medical aesthetics company focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments. They focus on the self-pay aesthetic market and their first product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kDa botulinum toxin type A complex designed to address the needs of the large and growing facial aesthetics market. They believe they will offer physicians and patients a compelling value proposition with DWP-450. Current... ly, onabotulinumtoxinA (BOTOX) is the neurotoxin market leader and the only known approved 900 kDa botulinum toxin type A complex in the United States. They believe aesthetic physicians generally prefer the performance characteristics of the complete 900 kDa neurotoxin complex and are accustomed to injecting this formulation. We have completed the clinical development program for DWP-450 for the treatment of moderate to severe glabellar lines ("frown lines") between the eyebrows in the US, EU, and Canada. The FDA issued a PDUFA date of May 15, 2018, for completion of its review of our BLA. We submitted an MAA to the EMA and a decision is expected by the second half of 2018. They have also submitted an NDS in Canada. They have an exclusive distribution license to DWP-450 from Daewoong Pharmaceuticals Co.

#SimilarOrganizations #People #Financial #Event #Website #More

EVOLUS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2012-01-01

Address:
Irvine, California, United States

Country:
United States

Website Url:
http://www.evolus.com

Total Employee:
251+

Status:
Active

Total Funding:
310.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

icosavax-logo

Icosavax

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Current Employees Featured

sandra-beaver_image

Sandra Beaver
Sandra Beaver Chief Financial Officer @ Evolus
Chief Financial Officer
2022-09-01

david-moatazedi_image

David Moatazedi
David Moatazedi President and CEO @ Evolus
President and CEO
2018-05-01

not_available_image

Christos Monovoukas
Christos Monovoukas Senior Vice President, Corporate Development @ Evolus
Senior Vice President, Corporate Development
2022-03-01

lauren-silvernail_image

Lauren Silvernail
Lauren Silvernail CFO and EVP Corporate Development @ Evolus
CFO and EVP Corporate Development
2018-01-01

estela-von-chong_image

Estela Von Chong
Estela Von Chong Sr. Manager, Regulatory Affairs, @ Evolus
Sr. Manager, Regulatory Affairs,
2021-01-01

jason-martell_image

Jason Martell
Jason Martell Senior User Experience @ Evolus
Senior User Experience
2019-06-01

rui-avelar_image

Rui Avelar
Rui Avelar Head of Research & Development and Chief Medical Officer @ Evolus
Head of Research & Development and Chief Medical Officer
2014-01-01

crystal-muilenburg_image

Crystal Muilenburg
Crystal Muilenburg Chief Marketing Officer @ Evolus
Chief Marketing Officer
2021-02-01

jessica-novak_image

Jessica Novak
Jessica Novak Senior Vice President @ Evolus
Senior Vice President
2021-10-01

Stock Details


Company's stock symbol is NASDAQ:EOLS

Investors List

pharmakon-advisors_image

Pharmakon Advisors

Pharmakon Advisors investment in Post-IPO Debt - Evolus

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Evolus

Official Site Inspections

http://www.evolus.com Semrush global rank: 770.29 K Semrush visits lastest month: 51.59 K

  • Host name: 23.185.0.1
  • IP address: 23.185.0.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Evolus" on Search Engine